; and (B) any barriers in access to care and participation in clinical trials that are specific to racial minorities. (6) Authorization of appropriations (A) In general Subject to subparagraph (B), there is authorized to be appropriated to carry out this section $100,000,000 for each of the fiscal years 2021 through 2025. (B) Specific allocations Of the amount authorized to be appropriated under subparagraph (A) for each of the fiscal years described in such paragraph— (i) no less than 10 percent may be appropriated to carry out the grant program under paragraph (2); and (ii) no more than 1 percent may be appropriated to carry out paragraph (4). (d) Public awareness and education campaign (1) National campaign The Secretary shall carry out a national campaign to increase the awareness and knowledge of Americans with respect to the need for prostate cancer screening and for improved detection technologies. (2) Requirements The national campaign conducted shall include— (A) roles for the Health Resources Services Administration, the Office on Minority Health of the Department of Health and Human Services, the Centers for Disease Control and Prevention, and the Office of Minority Health of the Centers for Disease Control and Prevention; and (B) the development and distribution of written educational materials, and the development and placing of public service announcements, that are intended to encourage men to seek prostate cancer screening and to create awareness of the need for improved imaging technologies for prostate cancer screening and diagnosis, including in-vitro blood testing and imaging technologies. (3) Racial Disparities In developing the national campaign under paragraph (1), the Secretary shall recognize and address— (A) the racial disparities in the incidences of prostate cancer and mortality rates with respect to such disease